John Richard Heys

Title: John Richard Heys: Innovator in Drug Binding Proteins

Introduction

John Richard Heys is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug binding proteins. With a total of 5 patents to his name, Heys has established himself as a key figure in innovation.

Latest Patents

Heys' latest patents focus on the development of antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins. This invention relates to drug binding proteins, genes encoding them, and methods for screening pharmaceuticals. More specifically, it addresses a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, along with the gene encoding it and assays useful in evaluating and characterizing drugs within this pharmacologic class. Another patent involves polynucleotides encoding cytokine suppressive anti-inflammatory drugs, further emphasizing his commitment to advancing pharmaceutical research.

Career Highlights

John Richard Heys is currently associated with SmithKline Beecham Corporation, where he continues to innovate and contribute to the field. His work has been instrumental in developing new therapeutic approaches that can potentially improve patient outcomes.

Collaborations

Heys has collaborated with notable colleagues such as Jerry Leroy Adams and Timothy Francis Gallagher. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

John Richard Heys is a distinguished inventor whose work in drug binding proteins has the potential to transform pharmaceutical development. His contributions are vital to advancing medical science and improving therapeutic options for patients.